IRIDEX Corporation (IRIX) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
IRIX Revenue Growth
Revenue Breakdown (FY 2024)
IRIX's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
IRIX Revenue Analysis (2013–2024)
As of May 9, 2026, IRIDEX Corporation (IRIX) generated trailing twelve-month (TTM) revenue of $50.6 million, reflecting solid growth of +7.8% year-over-year. The most recent quarter (Q3 2025) recorded $12.5 million in revenue, down 8.0% sequentially.
Looking at the longer-term picture, IRIX's 5-year compound annual growth rate (CAGR) stands at +2.3%, indicating moderate growth over time. The company achieved its highest annual revenue of $57.0 million in 2022.
Revenue diversification analysis shows IRIX's business is primarily driven by Retina (57%), Cyclo G Six (26%), and Product and Service, Other (17%). With over half of revenue concentrated in Retina, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including LASE (+177.0% YoY), ARAY (-7.9% YoY), and GKOS (+36.3% YoY), IRIX has underperformed the peer group in terms of revenue growth. Compare IRIX vs LASE →
IRIX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IRIXCurrent | $51M | +7.8% | +2.3% | -17.1% | |
 LASE | $3M | +177.0% | - | -189.3% | |
 ARAY | $459M | -7.9% | +3.7% | 1.7% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 ALGN | $4.0B | +2.9% | +10.3% | 15.3% |
IRIX Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $48.7M | -6.2% | $19.5M | 40.1% | $-8,302,000 | -17.1% |
| 2023 | $51.9M | -9.0% | $21.8M | 42.0% | $-10,007,000 | -19.3% |
| 2022 | $57.0M | +5.7% | $25.4M | 44.5% | $-7,542,000 | -13.2% |
| 2021 | $53.9M | +48.3% | $22.8M | 42.4% | $-7,533,000 | -14.0% |
| 2020 | $36.3M | -16.3% | $15.6M | 42.8% | $-6,583,000 | -18.1% |
| 2019 | $43.4M | +2.0% | $17.9M | 41.3% | $-8,974,000 | -20.7% |
| 2018 | $42.6M | +2.4% | $17.5M | 41.0% | $-12,868,000 | -30.2% |
| 2017 | $41.6M | -9.9% | $15.5M | 37.3% | $-12,888,000 | -31.0% |
| 2016 | $46.2M | +10.5% | $20.8M | 45.1% | $-2,565,000 | -5.6% |
| 2015 | $41.8M | -2.5% | $20.0M | 47.8% | $288K | 0.7% |
See IRIX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRIX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRIX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIRIX — Frequently Asked Questions
Quick answers to the most common questions about buying IRIX stock.
Is IRIX's revenue growth accelerating or slowing?
IRIX maintains +7.8% revenue growth, in line with its 5-year CAGR of +2.3%. TTM revenue stands at $51M. Growth rate remains consistent with historical average.
What is IRIX's long-term revenue growth rate?
IRIDEX Corporation's 5-year revenue CAGR of +2.3% reflects the sustained expansion pattern. Current YoY growth of +7.8% is near this long-term average.
How is IRIX's revenue distributed by segment?
IRIX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.